STAT+: PhRMA sues Biden administration over Medicare drug price negotiation program
WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.
The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.
PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.
Continue to STAT+ to read the full story…
